Fidelity Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5M | Buy |
3,048,019
+1,890,031
| +163% | +$12.1M | ﹤0.01% | 1709 |
|
|
2025
Q1 | $4.1M | Buy |
1,157,988
+426,632
| +58% | +$1.51M | ﹤0.01% | 2210 |
|
|
2024
Q4 | $2.76M | Buy |
731,356
+510,355
| +231% | +$1.93M | ﹤0.01% | 2342 |
|
|
2024
Q3 | $716K | Buy |
221,001
+164,622
| +292% | +$533K | ﹤0.01% | 2718 |
|
|
2024
Q2 | $107K | Buy |
56,379
+36,989
| +191% | +$70.3K | ﹤0.01% | 3270 |
|
|
2024
Q1 | $55.1K | Sell |
19,390
-1,416,761
| -99% | -$4.02M | ﹤0.01% | 3532 |
|
|
2023
Q4 | $21.1M | Buy |
1,436,151
+997,465
| +227% | +$14.7M | ﹤0.01% | 1603 |
|
|
2023
Q3 | $8.03M | Sell |
438,686
-10,296
| -2% | -$189K | ﹤0.01% | 1894 |
|
|
2023
Q2 | $9.68M | Buy |
448,982
+441,752
| +6,110% | +$9.53M | ﹤0.01% | 1876 |
|
|
2023
Q1 | $212K | Sell |
7,230
-574
| -7% | -$16.8K | ﹤0.01% | 2948 |
|
|
2022
Q4 | $288K | Buy |
7,804
+7,468
| +2,223% | +$276K | ﹤0.01% | 2897 |
|
|
2022
Q3 | $9K | Sell |
336
-122,107
| -100% | -$3.27M | ﹤0.01% | 4111 |
|
|
2022
Q2 | $2.36M | Buy |
122,443
+34,318
| +39% | +$661K | ﹤0.01% | 2456 |
|
|
2022
Q1 | $1.13M | Buy |
+88,125
| New | +$1.13M | ﹤0.01% | 2758 |
|